242 filings
Page 9 of 13
8-K
8oujgl
29 Oct 18
Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th
9:00am
8-K
2wh8 tbqb
5 Oct 18
Jaguar Health Announces Pricing of $9 Million Underwritten Public Offering
4:59pm
8-K
lfj48ru7q 3ovrcrq
28 Sep 18
Jaguar Health, Inc. Investor Presentation September 2018
9:24am
8-K
vxk 0x4k5re3x
25 Sep 18
Knight Therapeutics and Jaguar Health Announce Strategic Partnership
6:04am
8-K
plisdrxbtqsmdsn8luu
12 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
1yzew1
4 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
tgtmpe fu7b
12 Jul 18
Jaguar Health, Inc. Provides Second Quarter 2018 Financial Updates
9:01am
8-K
9tuilel776nc2
5 Jul 18
Entry into a Material Definitive Agreement
5:01pm
8-K
f6xct1
20 Jun 18
Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors
5:08pm
8-K
3ri 3e8a6i0mx
18 Jun 18
Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors
5:01pm
8-K
msz9f
1 Jun 18
Jaguar Health, Inc. Announces 1-for-15 Reverse Stock Split
9:00am
8-K
juz91fth02xia3iqma
29 May 18
Jaguar Health Appoints Robert J. Griffing Chief Commercialization Officer of Jaguar Subsidiary Napo Pharmaceuticals
9:00am
8-K
xav67418x3xj78e gji
18 May 18
Jaguar Health, Inc. Reports First-Quarter 2018 Operational Updates and Voting Results from 2018 Annual Meeting of Stockholders
5:28pm
8-K
5i52oyll009ec9lbl3d
18 May 18
Departure of Directors or Certain Officers
5:27pm
8-K
ni0dndl7
18 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
z5554g zkj16i7
2 Apr 18
Jaguar Health Appoints Jonathan B. Siegel to Board of Directors
12:00am
8-K
857tc1drdtpply
27 Mar 18
Largest Investor Locked In for 12 Months
12:00am
8-K
irxxt
12 Mar 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
kixk 16mru5qyxczt
2 Mar 18
Other Events
12:00am
8-K
sl8wjjx ss32
2 Mar 18
Entry into a Material Definitive Agreement
12:00am